KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Return on Equity (2018 - 2025)

Historic Return on Equity for ClearPoint Neuro (CLPT) over the last 12 years, with Q3 2025 value amounting to 1.31%.

  • ClearPoint Neuro's Return on Equity fell 7200.0% to 1.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.31%, marking a year-over-year decrease of 7200.0%. This contributed to the annual value of 0.85% for FY2024, which is 700.0% down from last year.
  • Per ClearPoint Neuro's latest filing, its Return on Equity stood at 1.31% for Q3 2025, which was down 7200.0% from 1.13% recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Return on Equity peaked at 0.22% during Q2 2021, and registered a low of 1.31% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.65%, with a median of 0.6% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 29500bps in 2021, then crashed by -7200bps in 2025.
  • ClearPoint Neuro's Return on Equity (Quarter) stood at 0.22% in 2021, then crashed by -96bps to 0.43% in 2022, then plummeted by -130bps to 0.99% in 2023, then rose by 29bps to 0.71% in 2024, then crashed by -86bps to 1.31% in 2025.
  • Its Return on Equity stands at 1.31% for Q3 2025, versus 1.13% for Q2 2025 and 0.93% for Q1 2025.